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Cytolytic lymphocytes provide a host resistance mechanism that may be exerted
against tumors, allografts, andcells infectedwith microbial agents, especially viruses
andsome bacteria. There areseveraltypes ofkiller cells(1): antigen-specific, MHC-
restricted CTL, as well as lymphokine-activated killer (LAK), and NK cells, which
have less well-defined specificities.
Cytolytic lymphocytes are typically generated in tissue culture using heteroge-
neous populationsofboth responderlymphocytes and APCs, aswell as some source
ofexogenous growth factors and othercytokines. Undersuch conditions, theprolifer-
ative and lytic responses by CD8+ lymphocytes are enhanced by the lymphokine
products ofhelper GD4+ cells, especially IL-2 (2-5). However, murine lymphocytes
depleted of CD4+ T cells can also independently generate CTL directed against
viral(6) and transplantation antigens (7-10). This developmentofCTL from helper-
depleted populations is induced by dendritic cells andisaccompanied bythe release
ofIL-2 (9). In man the cellular requirements forCytolytic lymphocyte development
have not been similarly analyzed, and itis often assumed that helper cells areessen-
tial. We willshow here that it is possibletoinduce Cytolytic cellsfrom purifiedhuman
CD4- lymphocyte populations in the primary MLR, as long as dendritic cells are
used as the stimulator cells or APCs. The use ofhuman cells has enabled us to de-
scribe several new features ofthe helper-independent response. Whereas in the mu-
rine MLR it is necessary to use heterologous serum in the cultures, and macro-
phages are inhibitory, the human response occurs in homologous serum, and
monocytes are neitherstimulatory norinhibitory. We willalso demonstratethatboth
antigen-specific CTL and antigen-nonspecific NK cells can be induced by human
dendritic cells, and that the number ofcells that transform into blasts and express
This work wassupported by grants K08 CA-00961, 1R29 AI-26875, P01 AI-24775, andROl AI-24540
from the National Institutes of Health, and by a grant from the New York Community Trust, Blood
Diseases Research Program.
Addresscorrespondence to Dr. James W.Young, TheRockefeller University, 1230 York Avenue, Box
280, New York, NY 10021.
￿
_
Abbreviations used in this paper: CTLp, CTL precursor; Er+~ , neuraminidase-treated sheep eryth-
rocyte rosette-positive/negativelymphocytes;GVHD,graft-vs.-host disease; LAK, lymphokine-activated
killer; NHS, normal human serum; TCGF, T cell growth factor.
J. Exp. MED. © The Rockefeller University Press - 0022-1007/90/04/1315/18 $2.00
￿
1315
Volume 171 April 1990 1315-13321316 CD4+-INDEPENDENT, HUMAN CYTOLYTIC LYMPHOCYTE RESPONSES
activation antigens is very high, as many as 30-40% of the cultured cells at day
4-5 of the primary MLR .
Materials and Methods
Culture Medium, Serum, Buffers.
￿
Cells were cultured in RPMI 1640 (Gibco Laboratories,
Grand Island, NY) supplemented with 1 mM glutamine (KC Biological, Lenexa, KS), 5 x
10-5 M 2-ME (Eastman Kodak, Rochester, NY), penicillin (100 Units/ml), streptomycin (100
Wg/ml) (Gibco Laboratories), and 10% serum. FCS (HyClone Laboratories, Sterile Systems,
Logan, UT) was heat inactivated for 30 min at 56'C. Normal human serum (NHS) was
obtained by venipuncture from fasting, healthy, untransfused male volunteer donors, clotted
in the presence of glass shards for 1 h at room temperature. The serum was clarified by cen-
trifugation (1,5008, 15 min), heat inactivated at 56°C for 30 min, and stored at -20 °C until
needed. Ca2'_ and Mgt+-free saline buffers were used for all washes, either as PBS or as
HBSS.
PBMC and Preparation of Leukocyte Subpopulations (11).
￿
Normal leukocyte concentrates
(Greater NY Blood Program, New York, NY; specimens yielding positive serology for hepa-
titis B or HIV were not used) were layered over Ficoll-Paque (Pharmacia Fine Chemicals,
Piscataway, NJ) and centrifuged at 1,000 8 for 20 min at room temperature. The cellular
interface was collected as a source of PBMC, washed in PBS or HBSS, and separated over
continuousPercoll density gradients as previously described (11). Low density cells from this
primary Percoll separation were used as a source of monocytes, and were further enriched
if necessary by an adherence step on tissue culture plastic. The high density fraction was
rosetted with neuraminidase-treated (Vibrio cholerae neuraminidase; Calbiochem-Behring Di-
agnostics, La Jolla, CA) sheep erythrocytes (Scott Laboratories, Fiskeville, RI), and sepa-
rated over Ficoll-Paque into erythrocyte rosette-negative (Er-) and erythrocyte rosette-posi-
tive (Er+) fractions. The Er` fraction was further purified by passage over a nylon wool
column (Fenwal Laboratories, Deerfield, IL) and used as a source of T cells. The Er- frac-
tion was cultured for -36 h, panned over human Ig-coated plates to deplete contaminant
monocytes, and then separated over a secondary Percoll gradient (11). Secondary low density
cells were used as an enriched source of DCs, whereas the secondary high density fraction
was predominantly B lymphocytes. This method routinely yielded an accessory cell popula-
tion of dendritic cells enriched to 40-80% purity (11).
An alternative simpler approach was to omit the first Percoll separation. Bulk mononuclear
cells were directly rosetted with neuraminidase-treated sheeperythrocytes for separation into
Er- and Er' fractions as above. The Er- cells were cultured in RPMI-10% NHS. Er cells
that remained adherent after -36 h of culture, or that readhered to tissue culture plastic
after -36 h culture, were used as a highly enriched source of monocytes with no difference
in the functional results described below. Er nonadherent cells were panned twice over
human Ig-coated plates to deplete monocytes (11), then separated over a continuous Percoll
density gradient to yield a DC-enriched low density fraction. The high density fraction from
this separation again consisted primarily of small B lymphocytes.
Cell PhenotypeAnalysis.
￿
The following mAbs were used either as purified Ig or as hybridoma
supernatants: anti-CD3 (OKT3/IgG2a, ATCC CRL 8001); anti-CD4 (Leu3a/IgGI, gift
of Dr. Robert Evans [New York, NY]; OKT4/IgG2a, ATCC CRL 8002); anti-CD8
(OKT8/IgG2a, ATCC CRL 8014); "Simultest" anti-CD4-FITC/anti-CD8-PE (Leu3a/IgGl-
FITC//Leu2a/IgGl-PE, Becton-Dickinson [B-D], Mountain View, CA); anti-CD11b
(OKMI/IgG2b, ATCC); anti-CD14 (3C10/IgG26, ATCC TIB 228); anti-CD16 (3G8/IgGl,
gift of Dr. Jay Unkeless [New York, NY]; Leullc/IgGI, B-D); anti-CD25 (antiTAC/IgG2a,
gift of Dr. T. Waldman [Bethesda, MD]); anti CD28 (9.3/IgG2b, gift of Dr. Paul Martin
[Seattle, WA]); anti-CD45R (Leu18/IgGI, B-D); anti-HLA DR/DQmonomorphic epitope
(9.3F10/IgG2a, ATCC HB 180); antiTCR a//3 chains (antiTCRI/IgGI, B-D); antiTCR 6
chain, common region (IgGI; T Cell Sciences, Cambridge, MA). In some cases, the mAbs
were directly conjugated with either FITC or PE; otherwise FITC-conjugated F(ab')2 goat
anti-mouse IgG + IgM (Grub, Scandic, Vienna, Austria) was used as a second-step reagentYOUNG AND STEINMAN
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for indirect staining. Stained cellswere analyzed by cytofluorography on a FACScan instru-
ment (Becton-Dickinson Immunocytometry Systems, Mountain View, CA).
Purification of TLymphocyte Subsets.
￿
Enriched populations ofCD4' and CD8' T cells were
purified by negative selection of antibody-coated lymphocytes, panned on goat anti-mouse
IgG-coated petri dishes. Briefly, Er' nylon wool nonadherent lymphocytes at 5-7 x 106
cells/ml were coated with hybridoma supernatants on ice for 30-45 min, at concentrations
previously determinedto yield strongly positive fluorescence. The cell suspensions were washed
three times in RPMI-57o FCS before panning. Pans were prepared using 60 or 100 mm
bacteriologic grade petri dishes (Falcon 1007 or 1005; Becton-Dickinson, Lincoln Park, NJ),
coated for 1 h at room temperature with 20 or 60 ug, respectively, of IgG fraction goat
anti-mouse IgG (Fc fragment; .y chain specific, Cappe10211-0121; Cooper Biomedical, Mal-
vern, PA) in PBS. These dishes were gently rinsed four times with cold PBS just before use.
The mAb-coated lymphocytes were resuspended in cold RPMI-5% FCS at 5 x 106 cells/ml,
and either 3 or 8 ml was added to 60- or 100-mm dishes, respectively. The pans were cen-
trifuged at 25 g at 4°C for 5 min in a swinging bucket rotor (Sorvall RC3B, rotor H6000A)
with slow acceleration and no brake. The pans were swirled and rotated 180°, then centrifuged
again in the same manner. Thereafter, nonadherent lymphocytes were gently washed from
the pans, and their purity as a negatively selected population was monitored by cyto-
fluorography (Fig. 1).
Panning was also used to deplete NK cells contained within a subpopulation of CDllb'/
CD28- and CD16' cells comprising part of the CD4- fraction (Fig. 1). This subset could
be depleted by adding the anti-CD11b mAb, OKMI, to the panning procedure. As shown
in Fig. 1, the starting Er' nylon wool nonadherent cells ("bulk T cells," left column of Fig.
1) contained major CD4' and CD8' subsets and minor fractions of cells that were
CDllb'/CD28- and CD16'. Inclusion of the anti-CDllb mAb OKMI, when removing CD4'
lymphocytes by panning, yielded populations depleted of the minor CD11b'/CD28-, CD16'
(right column of Fig. 1), and CD57' (not shown) subsets. The effect of OKMI was specific
since the CD11b subset was not depleted when anti-CD14/3C10 was used as a nonreactive,
isotype-matched control mAb for anti-CDllb/OKMI. The phenotype of these starting cell
populations was also maintained following stimulation in culture with allogeneic DCs (cf,
Results, Fig. 5).
MixedLeukocyteReactions.
￿
Stimulatory APCs for the human MLR were eitherbulk mono-
nuclear cells or one of the Er subsets enriched in monocytes, dendritic cells, or small B lym-
phocytes, as described above. APCs were irradiated (3,000 rad, "'Cs) and added to T lym-
phocytes at APC/T ratios of 1 :10 or lower, as indicated in the respective experiments. MLRs
were uniformly cultured in the presence ofRPMI-10% NHS, either in 16-mm, 24-well, flat-
bottomed (1 .5 x 106 T cells), 96-well flat-bottomed (1.5 or 2 x 105 T cells), or 96-well U-
bottomed (1 x 105 T cells) tissue culture plates (Costar, Cambridge, MA), according to the
needs of the particular experiment. The cultures were maintained at 37°C in humidified
6% C02 .
Proliferative activity in the MLR was measured by the incorporation of ['H]TdR (New
England Nuclear, Boston, MA) in the DNA of replicating cells. When MLRs were run in
16-mm macrowells, triplicate 100-p,1 aliquots were transferred to U-bottomed microwells, to
which 1 /,Ci ['H]TdR per well was added. MLRs cultured in microwells from the outset
were pulsed similarly. After 6 h of incubation, the wells were harvested on glass fiber filters
and counted. Responses have been reported as the mean cpm of triplicates.
Assay of T Cell Growth Factor in the MLR.
￿
Aliquots of MLR supernatants were harvested
at representative time points, frozen, then thawed and added in serial dilutions to cells from
the CTLL2 line in flat-bottomed microwells. 1 tiCi [3H]TdR was added to each microwell
at 18-24 h, and DNA synthesis in the presence of the MLR supernatants was compared with
that of CTLL2 cells cultured with graded doses of rIL-2 (reference 12; Biogen, Cambridge,
MA). The amount of T cell growth factor in the MLR supernatants was then expressed in
terms of units per milliliter of rIL-2.
Cytolytic TLymphocyte Assay.
￿
Cytolytic activity derived from the MLR was measured in
a standard 4-h 5 'Cr-release assay. When the MLRs were cultured in 16-mm macrowells, the1318 CD4+-INDEPENDENT, HUMAN CYTOLYTIC LYMPHOCYTE RESPONSES
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Phenotype of starting lymphocyte responders in the allogeneic MLR (cf., Fig. 5).
Er*, nylon wool nonadherent [NyW NA] lymphocytes were used as bulk T cells. Thetwo CD8'
enriched populations were CD4-/CD14- andCD4-/CDllb- lymphocytes negatively selected by
panningwith anti-CD4/OKT4andeither anti-CD14/3C10(negativecontrol) or anti-CDllb/OKMl.
Each population was stained with the indicatedmAbs and analyzed by cytofluorography. In the
two-coloranalyses, anti-CD8/Leu2a-PE is shownalongtheordinate, andanti-CD4/Leu3a-FITC
is illustrated along the abscissa. In the single color histograms, either FITC-conjugated mAbs
or two-step indirect staining with FITC-goat anti-mouse Ig and primary mAbs was used to de-
termine logo fluorescence alongthe abscissa. Majorsubpopulations of CD28' andCD3* lym-
phocytes are indicated (-) in themiddle and bottom rows, respectively. Minorsubpopulations
of CDIlb' and CD16' lymphocytes are indicated by (- - -) in the middle and bottom rows,
respectively. Negative controls stained with FITC-goat anti-mouse Ig but no primary mAb are
indicated by the unlabeled, dotted lines.
cells were harvested and transferred in graded doses to U-bottomed microwells, to which
5 or 10 x 10' radiolabeled target cells were added. Alternatively, when the MLRs were cul-
tured initiallyin U-bottomed microwells, the cells were gently resuspended; and 5 x 10' ra-
diolabeled targets were addeddirectly to the MLRmicrowells. CTLassays were runin tripli-
cates for each experimental condition.
Cultured human macrophageswere routinely used as allogeneic andsyngeneictarget cells
forCTL assays. Monocyteswere cultured in RPMI-10% NHS in Teflon beakersand labeled
with "Cr (New England Nuclear) as previously reported (13). The K562 cell line was "Cr-
labeled and used as targets for measurement of antigen-nonspecific lytic activity.The microtiter plates were incubated at 37'C, 617o C02 for 4 h. Thereafter, the plates were
spun at 15 g for 5 min at 37'C, and supernatant aliquots were harvested to measure 5'Cr
release. Spontaneous release was measured from target cells cultured without effectors in
medium only, and total release was measured from targets cultured in 0.1% SDS. Cytolytic
activity has been reported as the percent specific release of 5'Cr, calculated in standard
fashion as: percent specific release = 100 x [(mean cpm from triplicate test wells - sponta-
neousrelease)/(total release - spontaneous release)]. Spontaneous release was always <10-15%
of the total release for the experiments reported here.
Results
DendriticCells Induce theDevelopmentofAntigen-specific CTL andNKCells in theAbsence
ofCD4+ Helper Lymphocytes. It is widely accepted that the standard population of
stimulator cells in the human MLR, i.e., bulk mononuclear cells from peripheral
blood, is unable to stimulate allogeneic CTL in the absence of CD4+ lymphocytes
and their secreted "helper" lymphokines (14). Our initial goal was to test if, using
dendritic cells as APC, one could elicit responses from the CD4- population of
human blood lymphocytes. This was indeed the case in that allogeneic dendritic
cellscould induce the formation ofkillers that would preferentially attack allogeneic
vs. syngeneic monocytes as targets (Fig. 2). However, we noted that dendritic cells
also stimulated the formation of nonspecific killers, as evidenced by lysis of K562
target cells (Fig. 2).
It has been reported that all mature CD4 - lymphocyte effectors derive from one
of two precursor subsets characterized by reciprocal CD28 `/CDllb - "cytolytic" and
CD28-/CDllb+ "suppressor" phenotypes (15, 16). We tested if OKM1, an IgG2b
mAb against the CR3/CD11b epitope, could be used to deplete precursors of K562
lytic cells. Anti-C134 and anti-CDllb mAb were used together to pan populations
of nylon wool nonadherent lymphocytes (cf. Fig. 1 and Materials and Methods for
the efficiency of the panning procedure). 3010, a nonreactive IgG2b anti-CD14 mAb,
a)
N
cp
a)
N
L
U
U
w
U
a
to
+J
C a)
U
i
N
n
FicURE 2.
￿
Cytolytic activity derived
from primary MLRs stimulated by al-
logeneic blood dendritic cells. Lympho-
cyte responder populations were ob-
tained as described under Materials
and Methods and Fig. 1 (bulk T lym
phocytes,
￿
I; CD4-/CD14- lympho-
cytes, 0; CD4-/CDllb- lympho-
cytes, ®) and stimulated by allogene-
ic blood dendritic cells (3,000 rad,
1 ;7Cs) in U-bottomed microwells in
RPMI-10% NHS (responder/ stimu-
lator ratio of 25:1). After 4-5 d of cul-
ture, the cell targets indicated along the
abscissa were "Cr-labeled, and 5 x
]0' targets were added directly to the
microwells. PHA (10,ug/ml final) was
added to a parallel cohort of cultures
with "Cr-labeled allogeneic monocyte
Syngeneic M4
￿
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￿
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￿
PHA
￿
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￿
targets. The E/T ratio of the MLR cul-
Allogeneic M4
￿
tures was -30 :1 at the time the targets
were added. After a 4-h incubation, su-
51Cr-labelled Target
￿
pernatants were harvested for determi-
nation ofthe percent specific release as
shown along the ordinate.
Bulk T lymphocytes
CD4"CD 14-
® CD4-CD11b-
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wasthe isotype-matched controlforthe OKM1 mAb. Panningwith OKMI removed
the K562 cytolytic precursors without significantly altering thelevel ofantigen-specific
killing (Fig. 2). Note that the addition ofPHA during the CTL assay did not ap-
preciably augment the measurable lysis by CD4-/CDllb- effectors from the al-
logeneic MLR (Fig. 2). However, PHA did enhance killing by a lectin-dependent
mechanism by the bulk and CD4-/CD14- populations that contained nonspecific
lytic cells. The CTL assay therefore efficiently detected all of the antigen-specific
CTL response that developed from the allogeneic MLR, and these effectors devel-
oped primarily from the CD4-/CDllb- T cell precursors.
In dose-response studies (Fig. 3) we noted that very low levels of dendritic cells
were required to induce NK cell activity, whereas higher levels were required for
the induction ofCTL. Typically the required ratio ofdendritic cells to T cells was
1 :10 or 1:30. These doses are muchhigher than the numberofdendriticcellspresent
ifbulk mononuclear cells were used as stimulators ofCD4+ -independent CTL re-
sponses.
As in the mouse, helper-independent CD4- responses to histoincompatible den-
dritic cells usually peaked -24 h earlier than those ofa bulk T cell population con-
taining CD4+ helper lymphocytes (Fig. 4, A and B). The kinetics were identical
regardless of the CD4- subset used as responders (data not shown). In syngeneic
MLRs cultured in 10 0 1o human serum, only bulk T cells exhibited any measurable
proliferation (Fig. 4A), although it was markedly less than after allogeneic stimula-
tion. FCS supported a greater syngeneic response by both T cell populations (data
not shown), and we have therefore avoided its use in functional assays.
We conclude that allogeneic dendritic cells can induce the formation ofantigen-
specific and -nonspecific cytolytic cells in the absence ofCD4+ helper lymphocytes.
The precursors ofnonspecific NK/LAK type cells can be removed by panning with
an anti-CDllb mAb, OKMI, without altering the amount of antigen-specific CTL
that develops in the allogeneic CD4- MLR. The kinetics ofthe CD4- response are
rapid, and a syngeneic response is not observed by CD4- lymphocytes when cul-
tured in humanserum. These findingsarerepresentative ofmorethan 15 experiments.
CD4+ T Lymphocyte Contaminants Do Not Contribute to the CD4- MLR.
￿
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Kinetics of the primary
human MLR elicited by blood den-
dritic cells. Bulk T lymphocytes and
CD4-/CDllb- T cells were stimulated
in U-bottomed microwells (responder/
stimulator of 10:1) by syngeneicor al-
logeneic dendritic cells (3,000 rad,
13~ Cs) in the respective MLRs cul-
turedin RPMI-10% NHS. On theday
ofculture indicated alongtheabscissa,
the cultures were pulsed with 1 FACT/
well of [3H]TdR for 6-8 h and
proliferation wasmeasured in standard
fashion (A: bulk T lymphocyte re-
sponders, "; CD4-/CDllb- respon-
ders, O). Concomitantly, 5 x 103
51Cr-labeled syngeneic or allogeneic
monocytes were added to separate
MLR microwells, and supernatants
were harvested and counted after 4 h
for determination of percent specific
slCr release (B: allogeneic Mo targets,
"; syngeneic Mo targets, A).
low levels of CD4+ contamination (e.g., <2-3% as shown in Fig. 1), helper lym-
phocytes could proliferate disproportionately during the CD4- MLR and con-
tribute to the primary cytolytic responses illustrated above. We therefore pheno-
typed the responder lymphocytes after dendritic cell stimulation in the allogeneic
MLR. Cytofluorographic data confirmed the continued purity of the starting
CD4-/CD14- and CD4-/CD11b- populations (Fig. 5). Note the presence ofa trace,
but discrete subpopulation of S chain-positive T cells, comprising N3% of both
CD4- lymphocyte populations. These cells were also present to a similar degree
before stimulation (data not shown).
One of the hallmarks of CD4+ lymphocyte function is the production ofTcell
growth factor[s] [TCGF], amongwhich is IL-2. However, inthe "helper-independent"
CD4- allogeneic MLR measurable amounts ofTCGF were also found (Fig. 6). To
exclude the production ofsignificant amounts of IL-2 by trace contaminant CD4+
T lymphocytes, responder populations of bulk T lymphocytes and purified CD4-
lymphocytes were coated with anti-CD4 (Leu3a, 3hg/ml final) andthen stimulated
with allogeneic DCs in the continuous presence of anti-CD4. Responder popula-
tions stimulated in the absenceofanti-CD4 were cultured in parallel. Wethen com-
pared supernatants harvested at serial time points from these MLRs with graded
doses ofrIL-2 for their ability to support the growth of CTLL2 cells (12). TCGF
was readily detected in the allogeneic MLR when bulk T lymphocytes were stimu-
lated by blood dendritic cells, and there was a 75% reduction when the bulk T cell
responders were coated with anti-CD4. Smaller amounts ofTCGF were present in
the dendritic cell-stimulated CD4- MLR, but there was no significant inhibition1322 CD4`-INDEPENDENT, HUMAN CYTOLYTIC LYMPHOCYTE RESPONSES
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Production ofT cell
growth factor(s) by CD4- lym-
phocytes in the helper-indepen
dent allogeneic MLR. Bulk T
lymphocytes (" ) and CD4-
lymphocytes (/) were coated
°-°
￿
with an-fl ￿(Leu3a 3 Ag/ml ,
final) and then stimulated with
allogeneic dendritic cells in the
. Bulk r : DC + anti-CD4
￿
continuous presence of anti-
coa- ￿cos+/ DG
￿
CD4
￿
UnCOated lymphocytes , .
CD4-,
￿
CDa+/ DC + anti-CD4
￿
were stimulated and cultured
alongside in the absence ofanti-
CD4 (bulk T, O ; CD4- , p).
ALLOGENEIC MLR, H
￿
Supernatants were harvested at
serial time points and tested for
their ability to support the growth of the CTLL2 cell line (12). Activity is reported in units derived
from a standard curve with graded doses ofhuman rIL-2. In different experiments the absolute amounts
of measurable TCGF were not always the same, but the results were qualitatively similar, i.e., anti-CD4
significantly reduced the amount of TCGF produced by bulk T cells but not by CD4- lymphocytes,
regardless of the CD4- subset stimulated.
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ofthese negatively selected responders by anti-CD4. [3H]TdR incorporation by re-
sponderlymphocytes was alsomeasured inallogeneic MLR cultures run inparallel.
Anti-CD4/Leu3a inthisconcentration inhibitedproliferation bybulk Tcellresponders
by 45%, whereas it had no significant effect on [3H]TdR incorporation by CD4-
responders in the "helper-independent" allogeneic MLR. Similar findings have been
obtained using the more highly purified CD4-/CDllb- subset (data not shown).
Large Numbers of CD4-/CD11b- Lymphocytes Display Phenotypic Markers ofActivation
after Stimulation by Histoincompatible DCs. We phenotyped responding lymphocytes
in the MLR for activation markers such as the receptor for IL2 (17), the expression
of class II MHC (18, 19), and the absence of the CD45R epitope (20, 21) on the
large lymphoblasts. CD4-/CDllb- T cells exhibited these phenotypic markers of
activation only after primary stimulation by allogeneic dendritic cells (Fig. 7 A).
Neither allogeneic monocytes (Fig. 7 B) nor syngeneicDCs (not shown) could elicit
such activation markers, thestaining forwhichwasthesameas the backgroundstaining
ofunstimulated CD4-/CDllb- T cells (Fig. 7 C. Representative cytofluorographs
ofallogeneic dendritic cell-stimulated bulk Tlymphocytes are shown for compar-
ison (Fig. 7 D). We ascertained thatlarge, IL-2R+ cells comprised 43% ofthe allo-
reactive lymphocytes in the bulk T cell MLR and 33% ofthe alloreactive lympho-
cytes in the CD4-/CDllb - cells MLR after a 4-5-d culture. This is representative
of more than six experiments.
BloodDendntic CellsAretheMostActive Accessory Cellsfor UnsensitizedCTL Precursors.
￿
We
evaluated the APC requirements for a primary response by resting, naive CTL
precursors (CTLp) in the absence of CD4+ T cell help. Candidate APC popula-
tions were obtained as described (Materials and Methods; reference 11), irradiated
(3,000 rad, "'Cs), and added at different doses to negatively selected bulk CD4-
lymphocyte responders in 16mm macrowells. At peak proliferation in the MLR on
day 4-5, the cells were harvested and added to radiolabeled monocytes at the indi-
cated E/T ratios; "Crrelease was measured after 4 h (13). As shown in Fig. 8, den-1324 CD4+-INDEPENDENT, HUMAN CYTOLYTIC LYMPHOCYTE RESPONSES
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Large numbersof
CD4-/CDllb - lymphocytes
display activation markers after
stimulation by histoincompat-
ible dendritic cells in the helper-
independent MLR. CD4-/
CDllb- T cells were stimulated
by allogeneic dendritic cells (A)
or allogeneic monocytes (B)
(responder/stimulator of 10:1)
for 4-5 d in U-bottomed micro-
wells . Unstimulated CD4"/
CDllb- T cells (C) and allo-
geneic dendritic cell-stimulated
bulk T lymphocytes (D) (re-
sponder/stimulator of 10:1)
were cultured simultaneously
for comparison. At peak pro-
liferation, the MLRs were
stained directly in the U-bot-
tomed microwells with the in-
dicatedmAbs andanalyzed by
cytofluorography. Negative con-
trols stained with FITC-goat
anti-mouse Ig but no primary
mAb are illustrated in the far
left column .
dritic cells were the most active APC for stimulating cytolytic effector function in
a dose-dependent fashion and in the absence of CD4+ help .
We have previously reported that peritoneal macrophages couldinhibit a primary
CD8+ response in the murine system (9) . However, this was not the case using pri-
mary leukocyte isolates from human blood . Monocytesdid notinhibit the dendritic
cell-stimulated response even at high doses(Fig . 8) . Similarfindings pertained when
bulk T cells, comprised of both CD4+ andCD8+ responders, were assayed for pri-
mary cytolytic activity after allogeneic stimulation in the MLR (data not shown) .
We have similarly examined the APC requirements for more highly purified
CD4- populations depleted of CD11b+ NK/LAK precursors, with regard to both
proliferation and cytolytic activity. Blood dendritic were the most active APCs for
stimulation of both proliferation and cytolysis (Fig . 9, A and B) . The bulk Er- popu-
lation and the Er-FcR- populations contained a lowerproportion of dendritic cells,
and these stimulators elicited lower but measurable responses at the higher dose .
Monocyte depletion did not abrogate the observed responses, and adherent Er- cells
specifically enriched for monocytes did not display significant stimulatory capacity.N
A
50,
dl
y 40-
_U
N
U
30-
.5
20 a to
MLR
MLA stimulatory APC
￿
stiratio
￿
FIGURE 8.
￿
Comparison of APC activity in
" Dendritic cell:
￿
1:10
￿
eliciting primary CTL from CD4- allogeneic
O Dendritic cells
￿
1:30
￿
lymphocytes . CD4- lymphocytes were cultured
" Monocytes/macrophages
￿
1:3
￿
at 1.5 x
￿
106 cells per 16-mm macrowell and
* Mixed dendritic cells
￿
1:10
￿
stimulated with differentAPCpopulations at the
6 monocytes/macrophages
￿
1 :3
￿
indicated stimulator/responder ratios. At the end
of day 4, the responding lymphocytes in the
MLRs were harvested from the microwells,
counted, and added to triplicate U-bottomed
microwells for assay ofCTL activity against 10 4
5'Cr-labeled allogeneic M0 from the original
stimulator party . Supernatants were harvested
after a 4-h incubation and percent specific release
was calculated in standard fashion . SmallBlym-
phocytes or bulk PBMCs (not shown) were no
50:1
￿
15 :1
￿
5:1
￿
1.5:1
￿
more active as stimulators in the helper-inde-
Effector/Target Ratio
￿
pendent CD4- MLRs than were monocytes .
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Whether monocytes were used fresh or after 2 d of culture in 10% human serum
did not affect their function as APCs for unsensitized precursors (datanot shown) .
Bulk mononuclear cells or smallB lymphocytes were similarly inactive in eliciting
primary proliferative and cytolytic responses (data not shown) .
Blood Dendritic Cells, butnotMonocytes, Stimulate theDevelopmentofNonspecific Cytolytic
Lymphocytes. Antigen-nonspecific NK cells aredependent on lymphokine for their
activation and development (22-24). We therefore compared the capacity of blood
dendritic cells and monocytes to sensitize NK cell precursors in a bulkT cell popu-
FIGURE 9 . Comparison of APC activity in
eliciting primary responses by CD4-/CDllb-T
cells in the helper-independent allogeneic MLR.
CD4-/CDllb- lymphocytes were stimulated in
U-bottomed microwells by the indicated APC
populations [Bulk Er- , l ; adherent Er - ,
=; Er-FcR- ,®; dendritic cells,0) . The
responder/stimulator doses illustrated are 10 :1
(left) and 30 :1 (right) . At the end of day 4, the
microwells were pulsed with 1 p,Ci/well of
[ 1H]TdR for 6-8 h and incorporation was mea-
sured as an index of proliferation (A) . Concomi-
tantly, 5 x 10' ' ICr-labeled allogeneic M0
targets were added directly to separate MLR
microwells for a standard 4-h CTL assay (B) .1326 CD4+ -INDEPENDENT, HUMAN CYTOLYTIC LYMPHOCYTE RESPONSES
lation where the amount oflymphokine would not be limiting. As shown in Table
I, the percent specific lysis ofK562 targets correlated directly with the stimulatory
dose of histoincompatible dendritic cells and the amount ofproliferation. Mono-
cytes were neither active by themselves, nor inhibitory in combination with den-
dritic cells, in stimulating lytic effectors against K562 targets.
Discussion
Similar Features of the Murine and Human CD4- MLRs.
￿
As in the mouse (7, 9),
resting human lymphocytes that are extensively depleted ofCD4+ cells can be in-
duced by blood dendritic cells to synthesize DNA and develop cytolytic activity. In
both species CD4+ lymphocyte depletion is sufficiently complete that helper cells
are not detectable at the onset or during the CD4- MLR, and the responses are
not inhibited by anti-CD4 mAb. T cell growth factors are produced in both human
and murine CD4- MLRs. However, the magnitude and longevity oflymphokine
production and T cell growth are less than observed in populations containing
CD4' lymphocytes.
Other types ofAPCs in human blood, as in mouse spleen, are weak or inactive
in stimulating the CD4- MLR. Typically, the required ratio of dendritic cells to
T cells (e.g., 1:10 or 1:30) is much higher than the number ofdendritic cells that
are present when bulk mononuclear cells are used as stimulators. This probably
accounts for the fact that CD4+-independent cytolytic responses have not been pre-
viously described in the human.
The significance of the CD4- MLR is enhanced by experiments in vivo in the
mouse thathave shown that resistance to some infectious agents (6) and tumors (25)
can develop in the apparent absence of CD4+ T cells. For example, elimination of
CD4+ function by in vivo administration of anti-CD4 mAb has little effect on an
animal's capacity to develop CTLand to survive infection with ectromelia virus (6),
TABLE I
Blood Dendritic Cells, but not Monocytes, Stimulate Development of
K562 Lytic Cells in the Primary Allogeneic MLR
Dose of allogeneic stimulators [3,000 rad, "QCs]
added at time 0 to 1.5 x 105 BULK Er'
NyW NA lymphocytes
DC
￿
1 .5 x 104 ￿1 .0 x 104 ￿0 .5 x 104 ￿0
Mo
￿
0
￿
0.5 x 104 ￿1 .0 x 104 ￿1 .5 x 104
Percent specific 51Cr release against
￿
44%
￿
42%
￿
36%
￿
5%
K562 targets, day 4 of the MLR
[3H]TdR x 6 h, day 4 of
￿
55,674
￿
53,874
￿
48,079
￿
5,086
the MLR
1 .5 x 105 bulk T (Er' NyW NA) lymphocytes were stimulated in U-bottom microwells by dendritic cells
(DC) or adherent Er- monocytes (Mo). The DC or Mo were added either alone or in combination at the
doses indicated. On day 4, 5 x 10 5'Cr-labeled K562 cells were added to the microwells, and supernatants
were harvested after a 4-h incubation for determination of percent specific release. A parallel group of cul-
tures was pulsed for 6-8 h also on day 4, with 1 1ACi/well of [3H]thymidine to measure proliferation.
DC, blood dendritic cells. M0, blood monocytes. Er' NyW NA, SRBC rosette-positive, nylon wool nonad-
herent lymphocytes.YOUNG AND STEINMAN
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even though theneutralizingantibody response toectromelia ismarkedlysuppressed.
One unknown in interpreting these data is whether dendritic cells are capable of
presenting peptides derived from ectromelia in association with class I. It is possible
that antigen presentation on class I molecules by dendritic cells efficiently primes
a CD8+ response in the absence ofhelper cells. Ifother APCs are the only source
of class I MHC-peptide complexes during an immune response, there may be a
greater need for helper cells reactive with class II MHC-peptide complexes.
There are new features and implications, however, that have become evident in
the human CD4- MLR that were not apparent in the murine system. We will
discuss several of these.
Antigen-speck CTL and Antigen-nonspecific NK Cells Generated in the Dendritic Cell-
stimulated, Helper-independent CD4- MLR. During the CD4- MLR, lytic cells de-
velop that kill allospecific targets from the original stimulator as well as nonspecific
targets such as K562. The latter are standard targets for NK cells. Precursors of
these nonspecific lyticeffectors can be depleted by panningwith an anti-CD11bmAb,
aknown marker ofNKcells (26, 27). Anti-CD11b, but notacontrol anti-CD14mAb,
removes a minor CD4- subset ofCD11b+/CD28-, CD16' cells that isdistinct from
the major CD11b-/CD28+, CD16- subset. Negative selection by panning with anti-
CDllb, however, does not significantly abrogate the antigen-specific CTL that de-
velop in the helper-independent CD4- MLR.
It is possible that the NK cells that develop in the CD4- MLR do so becauseden-
dritic cells expressepitopes that are also carried by standard K562 targets. Alterna-
tively, the amount ofIL-2 secreted in the dendritic cell-stimulated CD4- MLR may
besufficient tosupport NKcellproliferation asabystander event. NKcellsare known
to expand in response to IL-2; but it is thought that expansion requires relatively
highdoses oflymphokine, since NK cells predominantlyexpress the p75 intermediate
affinity IL-2R (22-24).
A Large Number of Lymphocytes AreActivatedduring the CD4- MLR by Allogeneic Den-
dritic Cell Stimulation. Several changes in surface phenotype are known to accom-
panyhumanT cell activation. These includetheappearanceofthe p55IL-2R(CD25)
(17) and MHC class II molecules (18, 19). Correspondingly, activated Tlympho-
blasts do not express a CD45R epitope (20, 21). Using mAb to these antigens to
monitor the extent ofT cell stimulation at the single cell level, we find that at the
peak ofthe CD4-/CDllb - MLR, as many as 33°Io ofthe cells are enlarged T lym-
phoblasts expressing the activation phenotype CD25+/HLA-DR,DQ+/CD45R-.
Activation antigens and an increase in cell size do not develop ifthe stimulator cells
are allogeneic monocytes or syngeneic dendritic cells.
The frequency ofCD8+ T cells that respond to allogeneic dendritic cells seems
high, but can be explained if 1-10% of the CD8+ cells respond to allogeneic class
IMHC Ag and undergotwo to five cell divisions in 4-5 d. This figure is consistent
with the number of T cells that can respond to a full allogeneic MHC difference
in the rat (28, 29).
AllogeneicMonocytesAre Unable to Stimulate, butalso Do NotInhibit theHelper-independent
CD4- MLR. Other candidate APCs, notably monocytes and small B cells, do not
elicit a primary MLR by CD4- responders. Similar observations have been made
in the mouse, but in that species peritoneal macrophages also inhibit the function
of allogeneic dendritic cells (9). In man, blood monocytes are not inhibitory even1328 CD4+-INDEPENDENT, HUMAN CYTOLYTIC LYMPHOCYTE RESPONSES
at high monocyte/dendritic cell ratios (3.3:1). Sprent and Schaefer have described
a particular set of experimental conditions whereby certain populations of mouse
macrophages can stimulate DNA synthesis in CD4- lymphocytes (30). It is unlikely
that their populations were contaminated with dendritic cells, since the stimulators
did not induce a CD4+ MLR. However, in man the blood monocyte population
is consistently without APC activity for the primary MLR, whether used freshly
isolated from blood orafter2 d ofculture on Teflon-coated surfaces inhuman serum.
These apparent speciesdifferences mayreflect apotentialrole formacrophage-derived
cytokines that may have been present in the experiments ofSprent and Schaefer.
Monocytes are capable ofclass I alloantigen presentation sincetheycan be recog-
nized as specific targets by sensitized CD8+ CTL (13, 31) elicited by dendritic cells.
However, while naive, unsensitized CTLp form discrete aggregates with allogeneic
dendritic cells that are easily seen by microscopy within the first 12-24 h ofculture,
we observelittle ifany monocyteTcell cluster formation in our cultures. All ofthe
specific CTL response in the allogeneic MLR develops from these clustered
CTLp-dendritic cell aggregates, which can be separated from the nonclustering,
nonreactivelymphocytesby velocity sedimentation (our unpublished data). Thelack
ofprimary stimulatory function in monocytes may therefore be at the level ofcon-
tact formation between the APC and the resting, or unprimed CD8+ T cell. These
observations are consistent with many prior studies of CD4+ T cell responses in
which one ofthedistinct features ofdendritic cells as APCsis theircapacity to iden-
tify and bind antigen-specific lymphocytes from a pool of resting precursors (32,
33). We have tested whether ourculture conditions may limit monocyte-T cell con-
tact by virtue ofthe fact that monocytes adhere to tissue culture plastic. However,
we have cultured CD4- MLRs in small Teflon beakers to which monocytes do not
adhere, and we have still not observed clustering or a productive CD8+ response
(our unpublished data).
Implications of CD4+-independent Cytolytic Lymphocyte Responses for Transplanta-
tion. CTL directed against major and minor histocompatibility differences have
been implicated in graft-vs-hostdisease(GVHD)in both animal andhumanmodels
(34-39). Murine CD4+ (class II MHC restricted) and CD8+ (class I MHC re-
stricted) cells can both contribute to GVHD, although the relative contribution of
each subset varies with the minorhistocompatibility antigens under study (40). De-
spite apparent HLA identity and MLR compatibility, GVHD and graft rejection
remain well-recognized obstacles to the successful use of human allogeneic bone
marrow transplantation (41-44). The potential causes are legion, but include class
I major and possibly minorhistocompatibility differences that would be undetected
byavailableserologic reagents orby standard MLR testinginwhich bulkmononuclear
cells are used as stimulators.
Since alloreactive CD8+ T cells are detected in high frequency when dendritic
cells present allogeneic class I molecules, it may be more efficient to detect subtle
class I MHC incompatibilities using dendritic cells rather than bulk mononuclear
cells as stimulators. We have recently made several improvements in our dendritic
cell enrichment protocol so that yield and purity similar to that obtained from leu-
kocyte concentrates can be derived from 50-100 ml peripheral blood samples (our
unpublished data). The use of CD4- responder populations would also focus the
analysis on class I MHC incompatibilities that might otherwise be obscured by aWe express our appreciation to Lynne Wu, Steve Soergel, and Mary Crowley for technical
assistance; to Judy Adams for assistance with graphics; and to Jeffrey Ming and Drs. Nina
Bhardwaj and Angela Granelli-Piperno for helpful review and discussion of the manuscript.
Receivedfor publication 7 Decernber 1989.
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significant syngeneic response to class II MHC antigen by CD4' T cells. Human
CTL responses to minor transplantation antigens could also contribute to GVHD,
for which ample precedent exists in animal models where minorhistocompatibility
differences are better defined (34, 35, 40, 45). Again the use of dendritic cells might
help detect minorhistoincompatibilities in the human, particularly if both primary
and secondary MLRs are examined. Toward these ends we are initiating a clinical
study in which we are enriching dendritic cells for comparison ofAPC function with
blood mononuclear cells, to determine if it is possible to identify major and minor
histocompatibility differences undetected by standard tissue typing approaches.
Summary
Cytotoxic lymphocytes are typically generated from unfractionated suspensions
of human lymphocytes by stimulating with heterogeneous APCs and exogeneous
growth factors. We have found that human blood dendritic cells can directly stimu-
late allogeneic human CD8' T cells to proliferate and express antigen-specific cyto-
toxic activity. These primary responses, which are accompanied by the release of
T cell growth factor(s), are induced in the absence of CD4+ helper T cells and are
not inhibited by anti-CD4 mAb. Both antigen-specific CTL as well as nonspecific
NK cells can be elicited by dendritic cells. The NK cell response can be depleted
at the precursor level by panning with an anti-CDllb mAb, which removes a
CD11b +/CD28- , CD16' subset from the starting CD4- responders. Allogeneic
blood monocytes are neither stimulatory nor inhibitory of these primary CD4-
MLRs, even though monocytes present alloantigen in such a way as to be recog-
nized as specific targets for CTL that have been sensitized by dendritic cells. The
number of CD8+ cells that are blast transformed and express an activated pheno-
type (i .e., HLA DR/DQ+, CD25/IL-2R+, CD45R -) reaches 30-40% of the cul-
ture at day 4-5, the peak of the helper-independent response. We conclude that antigen-
presentation by dendritic cells is sufficient in itself to prime cytolytic precursors.
We speculate that using dendritic cell stimulators and CD4- responders in MLRs
may be more efficient than standard tissue typing approaches for the detection of
subtle, but important class I MHC-restricted histoincompatibilities in human trans-
plantation.
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